Angela Rigopoulos
145 Studley Road
Heidelberg, VIC 3084, Australia
Heidelberg, VIC 3084, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Altered Abundance of Barrier-Related Proteins in Brain Microvascular Endothelial Cells of the GL261 Mouse Model of Glioblastoma.
Journal: Molecular pharmaceutics
Published: October 18, 2025
Characterisation of mAb104 Antibody-Drug Conjugates Targeting a Tumour-Selective HER2 Epitope.
Journal: Cancers
Published: August 21, 2025
Using 16α-[18F]-Fluoro-17β-Estradiol PET to Visualize Estrogen Receptor α Expression in Human Breast Cancer Xenografts in Female Ovariectomized Mice.
Journal: Journal of visualized experiments : JoVE
Published: March 24, 2025
DNA-Dependent Protein Kinase Inhibitor Peposertib Enhances Efficacy of 177Lu-Based Radioimmunotherapy in Preclinical Models of Prostate and Renal Cell Carcinoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 26, 2024
Correction to: Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89Zr-labelled CI-8993.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 26, 2024
Characterization of an Estrogen Receptor α-Selective 18 F-Estradiol PET Tracer.
Journal: World journal of nuclear medicine
Published: August 22, 2024
Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2.
Journal: Molecular cancer therapeutics
Published: July 15, 2024
Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 16, 2024
Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89Zr-labelled CI-8993.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 03, 2023
Radiolabelling and preclinical characterisation of [89Zr]Zr-Df-ATG-101 bispecific to PD-L1/4-1BB.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 14, 2023
Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2.
Journal: Nuclear medicine and biology
Published: March 30, 2023
Last Updated: 09/26/2026